id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-277683-9cg90zbo	Panettieri, Reynold A.	Asthma and COVID: What are the Important Questions?	2020-06-22		.txt	text/plain	946	60	49	However, critical questions remain about the biologic and 40 clinical features that predispose to CSS and critical illness, including underlying comorbidities 41 such as asthma and the medications used to treat them. Older age and comorbidities, especially heart disease, hypertension, chronic obstructive 43 pulmonary disease (COPD), diabetes and obesity, are reported risk factors for the development 44 and progression of COVID-19 (3). However, controversy exists as to whether patients with 45 asthma manifest high or elevated rates of COVID-19 incidence. Inhaled steroids 62 have also been associated with decreased expression of angiotensin-converting enzyme 2 63 (ACE2), the co-receptor for SARS-CoV-2 raising the question of whether these drugs could Future studies should address whether inhaled steroids in patient with asthma and/or allergic 68 rhinitis increase or decrease risks of SARS-CoV-2 infection, and whether these effects different 69 across inhaled steroid types. Changes in medication 115 adherence among patients with asthma and COPD during the COVID-19 pandemic	./cache/cord-277683-9cg90zbo.txt	./txt/cord-277683-9cg90zbo.txt